Common Contracts

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, OR...

Neurologix Inc/De • April 30th, 2008 • Pharmaceutical preparations • New York

• Company
  Neurologix Inc/De
• Filed
  April 30th, 2008
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS CERTIFIES THAT, for value received, Corriente Master Fund, L.P. or its registered assigns (the “Holder”), from and after the date hereof, and subject to the terms and conditions herein set forth, is entitled to purchase from Neurologix, Inc., a Delaware corporation (the “Company”), at any time before 5:00 p.m. New York City time on April 28, 2015 (the “Termination Date”), 1,077,586 shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a price per share equal to the Warrant Price (as defined below) upon exercise of this Warrant pursuant to Section 5 hereof. The number of Warrant Shares is subject to adjustment under Section 2.

Contract

Neurologix Inc/De • November 21st, 2007 • Pharmaceutical preparations • New York

• Company
  Neurologix Inc/De
• Filed
  November 21st, 2007
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, OR HYPOTHECATED UNLESS AND UNTIL (I) REGISTERED UNDER THE ACT OR, (II) THE TRANSACTION IS EXEMPT FROM REGISTRATION UNDER THE ACT AND AN OPINION OF COUNSEL IN A FORM REASONABLY SATISFACTORY TO THE ISSUER OF THESE SECURITIES HAS BEEN RENDERED.